These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36602920)

  • 21. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term Cost-Effectiveness of Dexcom G6 Real-time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Patients With Type 1 Diabetes in the U.K.
    Roze S; Isitt J; Smith-Palmer J; Javanbakht M; Lynch P
    Diabetes Care; 2020 Oct; 43(10):2411-2417. PubMed ID: 32647050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
    Jackson MA; Ahmann A; Shah VN
    Diabetes Technol Ther; 2021 Mar; 23(S1):S27-S34. PubMed ID: 33534631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France.
    Roze S; Isitt JJ; Smith-Palmer J; Lynch P; Klinkenbijl B; Zammit G; Benhamou PY
    Diabetes Ther; 2021 Jan; 12(1):235-246. PubMed ID: 33165838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous glucose monitoring in persons with type 2 diabetes not using insulin.
    Cowart K; Updike WH; Franks R
    Expert Rev Med Devices; 2021 Nov; 18(11):1049-1055. PubMed ID: 34633261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
    Salam M; Bailey R; Calhoun P; McGill JB; Bergenstal RM; Price D; Beck RW
    Diabetes Technol Ther; 2023 Mar; 25(3):178-185. PubMed ID: 36472504
    [No Abstract]   [Full Text] [Related]  

  • 29. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How use of continuous glucose monitoring can address therapeutic inertia in primary care.
    Martens TW; Parkin CG
    Postgrad Med; 2022 Aug; 134(6):576-588. PubMed ID: 35584802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT-CGM system in Germany, Sweden and the United Kingdom (2018-2020).
    Acciaroli G; van der Linden J; Chao C; Walker TC; Oliver N
    Diabet Med; 2023 Feb; 40(2):e14946. PubMed ID: 36053809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
    Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
    Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
    Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
    Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics.
    Munshi M; Slyne C; Davis D; Michals A; Sifre K; Dewar R; Atakov-Castillo A; Toschi E
    Diabetes Technol Ther; 2022 Jan; 24(1):1-9. PubMed ID: 34524033
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement in Glucose Regulation Using a Digital Tracker and Continuous Glucose Monitoring in Healthy Adults and Those with Type 2 Diabetes.
    Dehghani Zahedani A; Shariat Torbaghan S; Rahili S; Karlin K; Scilley D; Thakkar R; Saberi M; Hashemi N; Perelman D; Aghaeepour N; McLaughlin T; Snyder MP
    Diabetes Ther; 2021 Jul; 12(7):1871-1886. PubMed ID: 34047962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial.
    Renard E; Riveline JP; Hanaire H; Guerci B;
    Diabetes Obes Metab; 2022 May; 24(5):859-867. PubMed ID: 34984786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.